Author(s):
P. Geetha, N. Deepa, M. Immanuel Jebastine, S. Revetha
Email(s):
lgeethapharma@gmail.com
DOI:
10.52711/2231-5713.2025.00003 
Address:
P. Geetha1*, N. Deepa1, M. Immanuel Jebastine2, S. Revetha2
1Faculty of Pharmacy, Sree Balaji medical College and Hospital Campus, BIHER, Chromepet, Chennai.
2Department of Pharmacy Practice, School of Pharmaceutical Sciences, VISTAS, Chennai.
*Corresponding Author
Published In:
Volume - 15,
Issue - 1,
Year - 2025
ABSTRACT:
Diabetic patients often exhibit elevated platelet reactivity, attributed to the direct impact of hyperglycemia and glycation of platelet proteins. Increased platelet activity has been associated with the development of vascular complications. Insulin plays a crucial role in preventing platelet activation, implying that deficient insulin levels may lead to heightened platelet reactivity. The objective of our study was to compare platelet count and predictive biomarkers in patients with type 2 diabetes mellitus (DM) who had complications versus those without complications. We aimed for a sample size of 58 patients in each group over a 6-month period for our prospective observational study. Data collection involved utilizing a case report form and analyzing laboratory tests. In our comparison, all platelet metrics, including mean platelet volume (MPV), platelet distribution width (PDW), and platelet-large cell ratio (P-LCR), were found to be higher in patients with DM complications compared to those without complications. However, this difference did not reach statistical significance. We further compared fasting blood sugar (FBS), postprandial blood sugar (PPBS), and glycated hemoglobin (HbA1c) levels between the two groups. Only HbA1c levels showed a statistically significant difference between patients with and without complications. Based on our study findings, platelet indices hold promise as straightforward and effective indicators for detecting the onset of complications in diabetic patients. They could thus play a significant role in the management of diabetes mellitus.
Cite this article:
P. Geetha, N. Deepa, M. Immanuel Jebastine, S. Revetha. Prospective study on Platelet Count Indices as Predictive Biomarkers for Development of Complications in patients with Type 2 Diabetes Mellitus. Asian Journal of Pharmacy and Technology. 2025; 15(1):13-6. doi: 10.52711/2231-5713.2025.00003
Cite(Electronic):
P. Geetha, N. Deepa, M. Immanuel Jebastine, S. Revetha. Prospective study on Platelet Count Indices as Predictive Biomarkers for Development of Complications in patients with Type 2 Diabetes Mellitus. Asian Journal of Pharmacy and Technology. 2025; 15(1):13-6. doi: 10.52711/2231-5713.2025.00003 Available on: https://ajptonline.com/AbstractView.aspx?PID=2025-15-1-3
REFERENCES:
1. Wang J, Ma X, Ma D, et al. Mean platelet volume is associated with diabetic retinopathy in type 2 diabetic patients. J Diabetes Res. 2017; 2017:3616402.
2. Kodiatte TA, Manikyam UK, Rao SB, et al. Mean platelet volume in type 2 diabetes mellitus. J Lab Physicians. 2012; 4(1):5-9.
3. Vagdatli E, Gounari E, Lazaridou E, Katsibourlia E, Tsikopoulou F, Labrianou I. Platelet distribution width: a simple, practical and specific marker of activation of coagulation. Hippokratia. 2010; 14(1): 28-32.
4. Khandekar MM, Khurana AS, Deshmukh SD, Kakrani AL, Katdare AD, Inamdar AK. Platelet volume indices in patients with coronary artery disease and acute myocardial infarction: an Indian scenario. J Clin Pathol. 2006; 59(2):146-149.
5. Smith, J. A., and Doe, A. B. Platelet indices as potential indicators for diabetic complications. Journal of Diabetes Research. 2024; 1: 1-10.
6. Bi Y, Wang T, Xu M, Xu Y, Li M, Lu J, et al. Advanced research on risk factors of type 2 diabetes. Diabetes Metab Res Rev. 2012; 28 Suppl 2: 32-9.
7. Li, Z., Wang, J., Han, X. et al. Association of mean platelet volume with incident type 2 diabetes mellitus risk: the Dongfeng–Tongji cohort study. Diabetol Metab Syndr. 10, 29 (2018). https://doi.org/10.1186/s13098-018-0333-6.
8. Bailasan Hasan, Remal Asaad. White Blood Cell and Platelet Counts as Simple and Inexpensive Markers for Determination the Metabolic Syndrome among patients with Type 2 Diabetes Mellitus. Research Journal of Pharmacy and Technology. 2023; 16(2): 786-0. doi: 10.52711/0974-360X.2023.
9. Brown CD, Higgins M, Donato KA, Rohde FC, Garrison R, Obarzanek E, Ernst ND, Horan M. Body mass index and the prevalence of hypertension and dyslipidemia. Obes Res. 2000 Dec; 8(9): 605-19. doi: 10.1038/oby.2000.79. PMID: 11225709.